Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8932673 | British Journal of Anaesthesia | 2014 | 6 Pages |
Abstract
The concept of rapid delivery of multiple blood products to the bedside of a massively haemorrhaging patient seems to be a logical approach to the management of the massively bleeding patient. However, controversy exists in the use of fixed blood component ratios. Assessing the extent of the coagulopathy through point-of-care testing might provide patients with product administration as needed, and avoid excessive transfusion and its associated complications.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
J.H. Waters,